- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 122.34M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.89M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $27.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.41M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $15.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $32.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $37.94M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $53.58M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $68.14M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $306.18M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $325.56M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 100.76M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $926K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$17.03M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $301.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $314.59M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.34M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $14.55M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.96M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$22.55M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.8M |